A Canadian study of high-use drugs released from eight sewage treatment plants indicates that effects on invertebrates, bacteria, and plants// in the aquatic receiving environment are unlikely. The study is published in the latest issue of Environmental Toxicology and Chemistry.
The pharmaceutical market is a booming industry. The manufacture of drugs is increasing to match its demand and use worldwide. In Canada alone, approximately 24,000 products, including human pharmaceutical and biological drugs, veterinary drugs, and disinfectants, are registered on Health Canada’s Drug Product Database.
None of these pharmaceuticals is absorbed entirely by the body; they often leave through urine and fecal matter. Then, domestic waste streams carry the excreted drugs to municipal wastewater treatment plants, private septic systems, or receiving water without treatment. Though sewage treatment plants can remove or degrade some of the drug compounds, many drugs and by-products are not removed effectively. Hence the major source of pharmaceuticals in the aquatic environment is from sewage treatment plants.
Across Atlantic Canada, the study’s researchers found ten acidic and two neutral pharmaceuticals in the effluents of eight sewage treatment plants. In the large bodies of receiving water, drugs generally were not detected at significant concentrations. However, in the small receiving streams, drug residues continued downstream for 17 km. Based on the results of laboratory toxicity tests, the researchers concluded that the concentrations measured were not causing harm.
Page: 1 Related medicine news :1
. FDA approves Watson Pharmaceuticals Oxytrol patch2
. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart3
. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine4
. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals5
. Top Pharmaceuticals Influence Doctors Prescriptions6
. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals7
. Personalized Medicine and Innovative Pharmaceuticals8
. Pravastatin Launched by Watson Pharmaceuticals9
. Tata Industries picks up stake in Indigene Pharmaceuticals10
. OPPI Opposes Draft National Pharmaceuticals Policy11
. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404